Evidence map›Paper›PMID 42020308›Full record

ArticleChemSusChem2026

A Three-Step Route to Functionalized Pyrrole-2,5-Dicarboxylic Acids from Galactaric Acid.

Giacomo Trapasso, Davide Dalla Torre, Marco Artuso, Fabio Aricò

Abstract read
In one paragraph

Article in ChemSusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Giacomo TrapassoCa' Foscari University of Venice, Department of Environmental Sciences, Informatics and Statistics, Mestre, Italy.ORCID https://orcid.org/0000-0001-8951-1461
Davide Dalla TorreCa' Foscari University of Venice, Department of Environmental Sciences, Informatics and Statistics, Mestre, Italy.ORCID https://orcid.org/0009-0002-4544-8717
Marco ArtusoCa' Foscari University of Venice, Department of Environmental Sciences, Informatics and Statistics, Mestre, Italy.
Fabio AricòCa' Foscari University of Venice, Department of Environmental Sciences, Informatics and Statistics, Mestre, Italy.ORCID https://orcid.org/0000-0002-9946-4803

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Galactaric acid (GalA), one of the key biomass-derived organic acids, serves as a promising starting material for the synthesis of several platform chemicals, including muconic acid, 2,5-furandicarboxylic acid (FDCA), and pyrones, which can replace conventional petroleum-based chemicals. Recently, GalA has also been investigated as a precursor for nitrogen-containing heterocycles, such as pyrrole-2,5-dicarboxylic acids (PDCAs), which find applications in macromolecular chemistry, metal-organic framework (MOF) synthesis, and polymer production. To date, only two procedures have been reported for the synthesis of N-substituted PDCAs (R-PDCA), in which either the final products were not isolated, or the overall process required up to six reaction steps. This work focuses on the development of a simple and scalable route to functionalized PDCA compounds starting from GalA. The optimized synthetic procedure enabled the high-yield production of a library of PDCA derivatives through a three-step process involving a 2-pyrone salt as a key intermediate. All the products were isolated without the need for any chromatographic purification and fully characterized. Metrics were used to evaluate the greenness of the presented process and to compare it with the two previously reported procedures, demonstrating the viability of this synthesis for obtaining N-substituted PDCA compounds.

Indexed as

aldaric acidsbiomass valorizationgalactaric acidgreen metricspyrrole

Identifiers

PMID42020308
PMCPMC13102553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.